Acorda Therapeutics (ACOR) Tops Q1 EPS by 18c
Get Alerts ACOR Hot Sheet
Price: $13.21 +10.92%
EPS Growth %: -139.7%
Financial Fact:
Selling, general and administrative: 54.81M
Today's EPS Names:
SHIM, KOD, HEWA, More
EPS Growth %: -139.7%
Financial Fact:
Selling, general and administrative: 54.81M
Today's EPS Names:
SHIM, KOD, HEWA, More
Join SI Premium – FREE
Acorda Therapeutics (NASDAQ: ACOR) reported Q1 EPS of $0.36, $0.18 better than the analyst estimate of $0.18. Revenue for the quarter came in at $71.25 million versus the consensus estimate of $70.95 million.
For earnings history and earnings-related data on Acorda Therapeutics (ACOR) click here.
For earnings history and earnings-related data on Acorda Therapeutics (ACOR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: RH, Estee Lauder rise; Tesla falls
- Volcon (VLCN) Reports 2023 Operational and Financial Results
- Eledon Pharmaceuticals, Inc. (ELDN) Tops Q4 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!